Vanguard Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $4.55B | Sell |
18,882,403
-158,037
| -0.8% | -$40.4M | 0.07% | 272 |
|
|
2025
Q3 | $5.21B | Buy |
19,040,440
+293,515
| +2% | +$80.2M | 0.08% | 245 |
|
|
2025
Q2 | $4.84B | Buy |
18,746,925
+253,223
| +1% | +$60.4M | 0.08% | 253 |
|
|
2025
Q1 | $4.14B | Buy |
18,493,702
+320,240
| +2% | +$74.8M | 0.07% | 262 |
|
|
2024
Q4 | $4.16B | Buy |
18,173,462
+160,590
| +0.9% | +$38.7M | 0.07% | 263 |
|
|
2024
Q3 | $4.4B | Buy |
18,012,872
+112,570
| +0.6% | +$25.2M | 0.08% | 251 |
|
|
2024
Q2 | $3.43B | Buy |
17,900,302
+130,536
| +0.7% | +$26.5M | 0.07% | 300 |
|
|
2024
Q1 | $3.52B | Buy |
17,769,766
+26,309
| +0.1% | +$4.82M | 0.07% | 294 |
|
|
2023
Q4 | $3.05B | Buy |
17,743,457
+173,635
| +1% | +$26.7M | 0.07% | 304 |
|
|
2023
Q3 | $2.6B | Sell |
17,569,822
-6,801
| -0% | -$1.23M | 0.06% | 316 |
|
|
2023
Q2 | $3.84B | Buy |
17,576,623
+60,070
| +0.3% | +$13.4M | 0.09% | 218 |
|
|
2023
Q1 | $3.84B | Buy |
17,516,553
+1,010,935
| +6% | +$219M | 0.1% | 204 |
|
|
2022
Q4 | $3.44B | Buy |
16,505,618
+243,774
| +1% | +$53.6M | 0.09% | 224 |
|
|
2022
Q3 | $3.55B | Buy |
16,261,844
+199,805
| +1% | +$45.5M | 0.1% | 193 |
|
|
2022
Q2 | $3.37B | Buy |
16,062,039
+194,582
| +1% | +$41.4M | 0.09% | 210 |
|
|
2022
Q1 | $3.85B | Buy |
15,867,457
+254,208
| +2% | +$61.5M | 0.09% | 218 |
|
|
2021
Q4 | $4.07B | Buy |
15,613,249
+55,424
| +0.4% | +$14.4M | 0.09% | 208 |
|
|
2021
Q3 | $4.1B | Buy |
15,557,825
+142,021
| +0.9% | +$38.8M | 0.1% | 179 |
|
|
2021
Q2 | $3.8B | Sell |
15,415,804
-70,054
| -0.5% | -$14.7M | 0.09% | 205 |
|
|
2021
Q1 | $3B | Buy |
15,485,858
+46,014
| +0.3% | +$9.23M | 0.08% | 252 |
|
|
2020
Q4 | $3.28B | Sell |
15,439,844
-204,669
| -1% | -$40.8M | 0.1% | 202 |
|
|
2020
Q3 | $2.68B | Sell |
15,644,513
-348,334
| -2% | -$64.3M | 0.09% | 215 |
|
|
2020
Q2 | $3.07B | Sell |
15,992,847
-137,607
| -0.9% | -$22.5M | 0.11% | 169 |
|
|
2020
Q1 | $2.38B | Buy |
16,130,454
+340,161
| +2% | +$54.2M | 0.1% | 184 |
|
|
2019
Q4 | $2.45B | Buy |
15,790,293
+143,324
| +0.9% | +$20.7M | 0.08% | 242 |
|
|
2019
Q3 | $2.11B | Buy |
15,646,969
+319,737
| +2% | +$41.9M | 0.08% | 269 |
|
|
2019
Q2 | $1.87B | Buy |
15,327,232
+212,459
| +1% | +$23.5M | 0.07% | 303 |
|
|
2019
Q1 | $1.57B | Buy |
15,114,773
+249,539
| +2% | +$25.8M | 0.06% | 345 |
|
|
2018
Q4 | $1.69B | Buy |
14,865,234
+297,429
| +2% | +$31.9M | 0.08% | 273 |
|
|
2018
Q3 | $1.68B | Buy |
14,567,805
+69,129
| +0.5% | +$7.57M | 0.07% | 331 |
|
|
2018
Q2 | $1.5B | Buy |
14,498,676
+38,860
| +0.3% | +$3.93M | 0.06% | 359 |
|
|
2018
Q1 | $1.42B | Buy |
14,459,816
+178,525
| +1% | +$16.9M | 0.06% | 369 |
|
|
2017
Q4 | $1.21B | Buy |
14,281,291
+141,115
| +1% | +$11.7M | 0.05% | 419 |
|
|
2017
Q3 | $1.09B | Buy |
14,140,176
+2,225,505
| +19% | +$170M | 0.05% | 434 |
|
|
2017
Q2 | $928M | Buy |
11,914,671
+378,964
| +3% | +$27.1M | 0.05% | 471 |
|
|
2017
Q1 | $830M | Buy |
11,535,707
+508,392
| +5% | +$35.1M | 0.04% | 504 |
|
|
2016
Q4 | $684M | Buy |
11,027,315
+341,179
| +3% | +$20.9M | 0.04% | 538 |
|
|
2016
Q3 | $692M | Sell |
10,686,136
-993,189
| -9% | -$66.1M | 0.04% | 517 |
|
|
2016
Q2 | $738M | Buy |
11,679,325
+1,114,598
| +11% | +$65.7M | 0.05% | 471 |
|
|
2016
Q1 | $611M | Buy |
10,564,727
+320,341
| +3% | +$18.1M | 0.04% | 515 |
|
|
2015
Q4 | $550M | Buy |
10,244,386
+212,360
| +2% | +$12M | 0.04% | 536 |
|
|
2015
Q3 | $511M | Buy |
10,032,026
+160,672
| +2% | +$8.65M | 0.04% | 548 |
|
|
2015
Q2 | $556M | Buy |
9,871,354
+353,609
| +4% | +$22.3M | 0.04% | 547 |
|
|
2015
Q1 | $683M | Buy |
9,517,745
+606,909
| +7% | +$39.4M | 0.05% | 463 |
|
|
2014
Q4 | $500M | Buy |
8,910,836
+33,419
| +0.4% | +$1.75M | 0.04% | 548 |
|
|
2014
Q3 | $437M | Sell |
8,877,417
-79,605
| -0.9% | -$4.05M | 0.03% | 558 |
|
|
2014
Q2 | $453M | Buy |
8,957,022
+127,127
| +1% | +$6.3M | 0.04% | 549 |
|
|
2014
Q1 | $395M | Buy |
8,829,895
+218,725
| +3% | +$9.82M | 0.03% | 585 |
|
|
2013
Q4 | $405M | Buy |
8,611,170
+55,224
| +0.6% | +$2.8M | 0.04% | 555 |
|
|
2013
Q3 | $452M | Buy |
8,555,946
+93,050
| +1% | +$4.51M | 0.04% | 482 |
|
|
2013
Q2 | $382M | Buy |
+8,462,896
| New | +$402M | 0.04% | 509 |
|
Other funds holding RMD
Vanguard Group's RMD Position: Q4 2025 in Review
Vanguard Group reduced its ResMed (RMD) stake by 0.83% in Q4 2025, selling an estimated $40.4M and leaving 18,882,403 shares worth $4.55B. The position accounts for 0.07% of the portfolio, ranked #272.
Vanguard Group first reported a position in RMD in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.21B in Q3 2025. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.
- Vanguard Group held 18,882,403 shares of ResMed worth $4.55B as of Q4 2025.
- Vanguard Group sold 158,037 ResMed shares in Q4 2025, an estimated $40.4M.
- ResMed made up 0.07% of Vanguard Group's portfolio in Q4 2025, its #272 holding.
- Vanguard Group first reported a position in ResMed in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's ResMed position peaked at $5.21B in Q3 2025.
- 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.